BBVA USA Bancshares, Inc. - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 158 filers reported holding ANIKA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
BBVA USA Bancshares, Inc. ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$669,000
-21.3%
16,411
-12.5%
0.03%
-27.3%
Q4 2020$850,000
+23.4%
18,755
-2.6%
0.04%
+12.8%
Q3 2020$689,000
-1.1%
19,253
+4.3%
0.04%
-7.1%
Q2 2020$697,000
+35.3%
18,461
+3.7%
0.04%
+13.5%
Q1 2020$515,000
-42.8%
17,807
+2.5%
0.04%
-27.5%
Q4 2019$900,000
-13.2%
17,370
-8.1%
0.05%
-23.9%
Q3 2019$1,037,000
+70.8%
18,895
+26.4%
0.07%
+81.1%
Q2 2019$607,000
+57.7%
14,950
+17.4%
0.04%
+54.2%
Q1 2019$385,000
+19.2%
12,737
+32.7%
0.02%
+4.3%
Q4 2018$323,000
-51.2%
9,600
-38.8%
0.02%
-41.0%
Q3 2018$662,000
+32.4%
15,689
+0.3%
0.04%
+21.9%
Q2 2018$500,000
-53.8%
15,642
-28.2%
0.03%
-54.3%
Q1 2018$1,083,000
-3.0%
21,780
+5.2%
0.07%
-1.4%
Q4 2017$1,117,000
+5.5%
20,708
+13.4%
0.07%
+2.9%
Q3 2017$1,059,000
+42.9%
18,257
+21.5%
0.07%
+40.8%
Q2 2017$741,000
+108.7%
15,030
+83.8%
0.05%
+104.2%
Q1 2017$355,0008,1780.02%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders